Edge Pharma Methacholine Challenge 5-Syringe Test Kit, Sterile Inhalation Solution recall — FDA D-0405-2022
Lack of Assurance of Sterility
Overview of recall records associated with Edge Pharma, LLC, including dates, categories and classifications where available.
Classification mix: Class II: 6, Class III: 1.
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Lack of Assurance of Sterility
Defective container; syringe content migrating past the seal of the plunger may cause a lack of assurance of sterility
Temperature Abuse; labeled with the incorrect room temperature (15-25 ¿C) storage conditions rather than the correct refrigerated (2 - 8 ¿C) storage conditions
Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.
Lack of Assurance of Sterility; the media used to conduct post-compounding sterility testing for the Methotrexate product was expired.
This page summarizes recall records in which the official source identifies Edge Pharma, LLC as the recalling firm or manufacturer. The number of records should not be treated as a safety rating or a measure of company size, because recall counts depend on product mix, reporting periods and how government records are organized.
Compare the dates, categories and classifications together rather than relying on the total alone. Open an individual record for the recalled product, reason, distribution details and current instructions available from the source.